|
|
|
|
LEADER |
00000cam a2200000 i 4500 |
001 |
EBSCO_ocn936547717 |
003 |
OCoLC |
005 |
20231017213018.0 |
006 |
m o d |
007 |
cr ||||||||||| |
008 |
151009s2016 nyu ob 001 0 eng |
010 |
|
|
|a 2020678074
|
040 |
|
|
|a DLC
|b eng
|e rda
|c DLC
|d N$T
|d YDXCP
|d OCLCF
|d EBLCP
|d SNK
|d DKU
|d AUW
|d MHW
|d IGB
|d D6H
|d VTS
|d AGLDB
|d AU@
|d G3B
|d S8J
|d S9I
|d STF
|d OCLCO
|d OCLCQ
|d OCLCO
|
020 |
|
|
|a 9781634840262
|q (ebook)
|
020 |
|
|
|a 1634840267
|
020 |
|
|
|z 9781634840255
|
020 |
|
|
|z 1634840259
|
029 |
1 |
|
|a AU@
|b 000062420048
|
035 |
|
|
|a (OCoLC)936547717
|
042 |
|
|
|a pcc
|
050 |
0 |
0 |
|a RC280.L5
|
060 |
|
4 |
|a WI 735 H473 2016
|
072 |
|
7 |
|a HEA
|x 039000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 014000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 022000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 112000
|2 bisacsh
|
072 |
|
7 |
|a MED
|x 045000
|2 bisacsh
|
082 |
0 |
0 |
|a 616.99/436
|2 23
|
049 |
|
|
|a UAMI
|
245 |
0 |
0 |
|a Hepatocellular carcinoma in the 3rd millennium /
|c Massimiliano Berretta and Bruno Cacopardo, editors.
|
264 |
|
1 |
|a New York :
|b Nova Science Publishers Inc.,
|c [2016]
|
264 |
|
4 |
|c ©2016
|
300 |
|
|
|a 1 online resource.
|
336 |
|
|
|a text
|b txt
|2 rdacontent
|
337 |
|
|
|a computer
|b c
|2 rdamedia
|
338 |
|
|
|a online resource
|b cr
|2 rdacarrier
|
490 |
1 |
|
|a Cancer etiology, diagnosis and treatments
|
504 |
|
|
|a Includes bibliographical references and index.
|
588 |
|
|
|a Description based on print version record and CIP data provided by publisher.
|
505 |
0 |
|
|a HEPATOCELLULAR CARCINOMA IN THE 3RD MILLENNIUM ; HEPATOCELLULAR CARCINOMA IN THE 3RD MILLENNIUM ; Library of Congress Cataloging-in-Publication Data; CONTENTS ; PREFACE ; Chapter 1 THE EPIDEMIOLOGY OF HEPATOCELLULAR CARCINOMA ; ABSTRACT ; INTRODUCTION ; PRIMARY LIVER CANCER: A GLOBAL EPIDEMIOLOGICAL OVERVIEW ; FOCUS ON WESTERN COUNTRIES: INCIDENCE AND MORTALITY RATES IN THE US AND EUROPE ; THE EPIDEMIOLOGY OF RISK FACTORS FOR HCC ; CONCLUSION ; REFERENCES ; Chapter 2 RISK FACTORS FOR HEPATOCELLULAR CARCINOMA ; ABSTRACT ; INTRODUCTION ; CHRONIC VIRAL HEPATITIS ; ALCOHOL
|
505 |
8 |
|
|a NON-ALCOHOLIC FATTY LIVER DISEASE OTHER RISK FACTORS ; CONCLUSION ; REFERENCES ; Chapter 3 HEPATOCELLULAR CARCINOMA GENETIC LANDSCAPE; ABSTRACT; INTRODUCTION; HISTOPATHOLOGICAL CARCINOGENESIS: AN OVERVIEW ; WNT PATHWAY ; DNA INTEGRITY AND CELL CYCLE CONTROL ; CHROMATIN REMODELING ; RAS AND PI3K SIGNALING ; OXIDATIVE STRESS RESPONSE PATHWAY ; DIFFERENTIATION AND DEVELOPMENT ; CONCLUSION ; REFERENCES ; Chapter 4 NON-INVASIVE DIAGNOSIS OF HEPATOCELLULAR CARCINOMA ; INTRODUCTION ; HEPATOCARCINOGENESIS ; ULTRASONOGRAPHY ; CONTRAST-ENHANCED ULTRASONOGRAPHY (CEUS) ; COMPUTED TOMOGRAPHY (CT)
|
505 |
8 |
|
|a MAGNETIC RESONANCE IMAGING (MRI) CONCLUSION ; REFERENCES ; Chapter 5 SCREENING AND SURVEILLANCE: HEPATOCELLULAR CARCINOMA ; ABSTRACT; INTRODUCTION ; TARGET POPULATION ; Screening and Surveillance Tests ; SURVEILLANCE INTERVAL ; RECALL POLICY ; FUTURE PERSPECTIVES ; CONCLUSION ; REFERENCES ; Chapter 6 PRIMARY PREVENTION OF HEPATOCELLULAR CARCINOMA ; ABSTRACT ; INTRODUCTION ; PREVENTION OF HBV-RELATED HCC ; PREVENTION OF HCV-RELATED HCC ; Other Strategies of Prevention ; REFERENCES ; Chapter 7 NATURAL HISTORY OF HEPATOCELLULAR CARCINOMA ; ABSTRACT; INTRODUCTION
|
505 |
8 |
|
|a THE TUMOR ASSOCIATED TO CHRONIC HEPATIC DISEASE EARLY TUMOR ; INTERMEDIATE TUMOR ; ADVANCED TUMOR ; TERMINAL TUMOR ; THE CAUSES OF DEATH ; THE PREDICTIVE FACTORS OF DEATH ; TUMOR ON HEALTHY LIVER ; FIBROLAMMELLAR CARCINOMA ; CONCLUSION ; REFERENCES ; Chapter 8 CLINICO-PATHOLOGICAL AND MOLECULAR FINDINGS IN HEPATOCELLULAR CARCINOMA ; ABSTRACT ; INTRODUCTION ; PATHOLOGY ; Surveillance and Clinical Aspects for Early Detection of HCC ; Nomenclature of Small Hepatocellular Nodules ; Small and Early HCC ; Small and Progressed HCC ; ROLE OF BIOPSY SAMPLING IN HCC DIAGNOSIS ; ADVANCED HCC
|
505 |
8 |
|
|a Macroscopic Morphology HISTOLOGY ; Special Types of HCC ; Recently Discovered Subtypes ; GRADING ; HCC VERSUS METASTATIC NEOPLASMS ; Immunoistochemistry ; OVERVIEW OF CURRENT HCC STAGING SYSTEMS ; TNM ; Okuda Score ; BCLC Staging Classification ; CLIP Score ; Japan Integrated Staging (JIS) ; Chinese University Prognostic Index (CUPI); Groupe d'Etude et de Traitement du Carcinome Hépatocellulaire (GRETCH) ; CLINICAL STAGING COMMENTS ; THERAPEUTIC MARKERS FOR HCC ; AKT and Wnt/B-Catenin Pathways ; p-RPS6 Protein and mTOR Pathway ; Expression Profiling ; Epigenetics ; Metabolomics ; CONCLUSION
|
590 |
|
|
|a eBooks on EBSCOhost
|b EBSCO eBook Subscription Academic Collection - Worldwide
|
650 |
|
0 |
|a Liver
|x Cancer.
|
650 |
1 |
2 |
|a Carcinoma, Hepatocellular
|x diagnosis
|
650 |
|
2 |
|a Liver Neoplasms
|
650 |
|
6 |
|a Foie
|x Cancer.
|
650 |
|
7 |
|a HEALTH & FITNESS / Diseases / General
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Clinical Medicine
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Diseases
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Evidence-Based Medicine
|2 bisacsh
|
650 |
|
7 |
|a MEDICAL / Internal Medicine
|2 bisacsh
|
650 |
|
7 |
|a Liver
|x Cancer
|2 fast
|
700 |
1 |
|
|a Berretta, Massimiliano,
|e editor.
|
700 |
1 |
|
|a Cacopardo, Bruno,
|e editor.
|
776 |
0 |
8 |
|i Print version:
|t Hepatocellular carcinoma in the 3rd millennium
|d New York : Nova Science Publishers Inc., [2016]
|z 9781634840255
|w (DLC) 2015954516
|
830 |
|
0 |
|a Cancer etiology, diagnosis, and treatments.
|
856 |
4 |
0 |
|u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=1164795
|z Texto completo
|
938 |
|
|
|a YBP Library Services
|b YANK
|n 12652376
|
938 |
|
|
|a EBSCOhost
|b EBSC
|n 1164795
|
938 |
|
|
|a ProQuest Ebook Central
|b EBLB
|n EBL4586131
|
994 |
|
|
|a 92
|b IZTAP
|